Engert et al, JCO 2009
p <0,001
Years
A (64%)
B (70%)
C (82%)
Percentage
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
18%
GHSG HD9 Trial
FFTF by treatment arm